caffeic acid phenethyl ester has been researched along with Prostatic Neoplasms in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
Authors | Studies |
---|---|
Clabault, H; Hébert, MJ; Jean-François, J; Lassalle-Claux, G; Paré, AF; Patton, C; Sanderson, JT; Surette, ME; Touaibia, M | 1 |
Anjaly, K; Tiku, AB | 1 |
Chuu, CP; Fu, YK; Hour, TC; Huang, SH; Kuo, YY; Lin, CY; Tseng, JC; Wang, BJ | 1 |
Chen, JK; Chuu, CP; Hour, TC; Hsiao, PJ; Kao, CL; Kuo, LK; Kuo, YY; Shih, LJ; Tseng, JC; Wang, BJ; Wang, YP; Yeh, CC | 1 |
Chuu, CP; Hsu, JM; Kuo, LK; Liu, CC | 1 |
Abdel-Naim, AB; Abdel-Rahman, SZ; Al-Abd, AM; Azab, SS; Esmat, A; Khalifa, AE; Mosli, HA; Tolba, MF | 1 |
Chu, L; Fang, JM; Han, H; Li, CY; Liu, X; Xu, Q; Zhang, X; Zhao, HX | 1 |
Chuu, CP; Fu, HH; Lin, CY; Su, LC; Tseng, JC; Yang, SD | 1 |
Chuu, CP; Jiang, SS; Lin, HP | 1 |
Chuu, CP; Ciaccio, MF; Hause, RJ; Hiipakka, RA; Jones, RB; Kokontis, JM; Liao, S; Lin, HP | 1 |
Akyol, O; Akyol, S; Erden, G; Ginis, Z; Gurel, A; Ozturk, G | 1 |
Coffey, R; Fitzpatrick, JM; McEleny, K; Morrissey, C; Watson, RW | 1 |
Farrar, WL; Hodge, DR; Wang, L; Xiao, W; Yang, X; Zhang, X | 1 |
1 review(s) available for caffeic acid phenethyl ester and Prostatic Neoplasms
Article | Year |
---|---|
The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers.
Topics: Antineoplastic Agents; Caffeic Acids; Humans; Lung Neoplasms; Male; Melanoma; Phenylethyl Alcohol; Prostatic Neoplasms | 2012 |
12 other study(ies) available for caffeic acid phenethyl ester and Prostatic Neoplasms
Article | Year |
---|---|
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Topics: Antineoplastic Agents; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cinnamates; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2013 |
Caffeic acid phenethyl ester induces radiosensitization via inhibition of DNA damage repair in androgen-independent prostate cancer cells.
Topics: Androgens; Apoptosis; Caffeic Acids; Cell Line, Tumor; DNA Damage; DNA Repair; Humans; Male; Phenylethyl Alcohol; Prostatic Neoplasms | 2022 |
Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference.
Topics: Androgen Antagonists; Animals; Apoptosis; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Male; Mice; Mice, Nude; Phenylethyl Alcohol; Prostatic Neoplasms; Quality of Life | 2022 |
Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells.
Topics: Animals; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Humans; Male; Mice; Mice, Nude; Phenylethyl Alcohol; Phosphatidylinositol 3-Kinases; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt | 2023 |
Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer.
Topics: Caffeic Acids; Chemotherapy, Adjuvant; Humans; Male; Phenylethyl Alcohol; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt | 2013 |
Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Caffeic Acids; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Drug Synergism; Estrogen Receptor alpha; Estrogen Receptor beta; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Inhibitory Concentration 50; Male; Paclitaxel; Phenylethyl Alcohol; Prostatic Neoplasms; Taxoids | 2013 |
[Impact of NF-kappaB inhibitor on STAT3 translocation in PC-3 prostate cancer cell line].
Topics: Caffeic Acids; Cell Line, Tumor; Humans; Interleukin-6; Male; NF-kappa B; Phenylethyl Alcohol; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2013 |
CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.
Topics: Animals; Caffeic Acids; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phenylethyl Alcohol; Prostatic Neoplasms; Transfection; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeic Acids; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; Humans; Male; Microarray Analysis; p21-Activated Kinases; Phenylethyl Alcohol; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2012 |
Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.
Topics: Animals; Caffeic Acids; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytotoxins; Down-Regulation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oncogene Protein v-akt; Phenylethyl Alcohol; Prostatic Neoplasms; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins.
Topics: Apoptosis; Blotting, Western; Caffeic Acids; Caspase Inhibitors; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Male; NF-kappa B; Paclitaxel; Phenylethyl Alcohol; Prostatic Neoplasms; Tumor Necrosis Factor-alpha | 2004 |
Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells.
Topics: Base Sequence; Binding Sites; Blotting, Western; Caffeic Acids; CCAAT-Enhancer-Binding Protein-beta; DNA; Gene Expression Regulation; Humans; I-kappa B Proteins; Immunohistochemistry; Interleukin-6; Male; Molecular Sequence Data; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylethyl Alcohol; Promoter Regions, Genetic; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2004 |